Biohit Oyj

Report Publication Announcement • May 28, 2021

Publication of Biohit Oyj Renumeration Report 2020

Publication of Biohit Oyj Renumeration Report 2020

Biohit Oyj Renumeration Report May 28, 2021 at 02:00 pm local time (EET)

Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in
PDF format. The Remuneration Report for the Governing Bodies is attached to this
stock exchange release and also available at
https://www.biohithealthcare.com/en/investors/.

Additional information:
Chairman of the Board Osmo Suovaniemi, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=F7USWVHKzHva
X-wfSDZQcANme4hiXnyDOMsYd7_hh0-v5DJ8cXf2bZjeB
-DIAzDZFpopELnpgMmEnA_kpyYmLGTqvkGETAk2QfpwclEc6SE=)

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and services
to promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share
(BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare
group. www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=c5rWy
QltbzVNETEAzPUZ5WLkdGhFEQ1oTBo35iEHNX8xhFJ8UXxKcBfwNUj1oaJLkJWDIfhT0_qN_43uOPrHsI
IWy25pE_7iX8aTY-nisGmlggNS87UH1ViJkQ-0ezca)

Attachments: